Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Early Phase 1

1(12.5%)

Phase 4

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(5)

Early Phase 1(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05265741Unknown

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Role: lead

NCT04829006Not ApplicableCompleted

Intelligibility Assessment for Parkinson's Disease

Role: lead

NCT03310970Phase 4Completed

Pharmacokinetics of Lidocaine in Healthy Adults

Role: collaborator

NCT03990324Not ApplicableCompleted

Cervical Range of Motion and Stretching

Role: collaborator

NCT03813329Early Phase 1Completed

Effects of Novel Sodium Bicarbonate Ingestion of Buffering Capacity

Role: lead

NCT02329015Phase 1Completed

Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools

Role: lead

NCT01580280Not ApplicableCompleted

Manual Therapy and Exercise in Patients With Cervicogenic Headache

Role: collaborator

NCT02025569Not ApplicableTerminated

The Effect of Strain-counterstrain on Ankle Instability

Role: lead

NCT01542359Not ApplicableCompleted

Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension

Role: lead

All 9 trials loaded